 |
PDBsum entry 6hdu
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
6hdu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Small GTPases
12:133-146
(2021)
|
|
PubMed id:
|
|
|
|
|
| |
|
LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner via its armadillo domain.
|
|
E.McGrath,
D.Waschbüsch,
B.M.Baker,
A.R.Khan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
LRRK2 is a multi-domain Ser/Thr kinase that is associated with inherited and
sporadic cases of Parkinson's disease. Many mutations linked to disease are
associated within a central ROC-COR regulatory region and the subsequent kinase
domain, leading to enhanced catalytic activity. The N-terminus of human LRRK2
consists of armadillo repeat motifs (ARMs) followed by ankyrin repeats (ANKs).
Recently, Rab GTPases have emerged as key players in LRRK2 function, both as
substrates of the kinase, and as regulators of the catalytic activity. Rabs
recruit effector proteins via their GTP-dependent switch 1 and 2 regions
to distinct sub-cellular compartments to regulate membrane trafficking. LRRK2
phosphorylates Rab8, Rab10 and Rab12 in switch 2, and this activity is regulated
via interactions with Rab29. Furthermore, the related Rab32-subfamily
GTPases, Rab32 and Rab38, have also been shown to interact with LRRK2. Here, we
have mapped the interactions of the Rab32-subfamily to the ARM domain of LRRK2.
The complexes are dependent on the GTP state of the Rabs in vitro,
implying that LRRK2 may be an effector of the Rab32-subfamily of small GTPases.
X-ray crystal structures of the Rab32-family GTPases and subsequent mutational
studies reveal that a positively charged residue in switch 1 is critical for
binding of Rab32/38 to LRRK2. Homology modelling and mutational analyses of the
ARM domain point to a patch of negatively charged residues that contribute to
complex formation. These structural and biochemical studies provide a framework
for understanding the molecular basis for Rab regulation of LRRK2 and its role
in Parkinson's disease.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |